Search details
1.
A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.
Blood
; 137(7): 896-907, 2021 02 18.
Article
in English
| MEDLINE | ID: mdl-32976576
2.
Patient self-reporting of tolerability using PRO-CTCAE in a randomized double-blind, placebo-controlled phase II trial comparing gemcitabine in combination with adavosertib or placebo in patients with platinum resistant or refractory epithelial ovarian carcinoma.
Gynecol Oncol
; 167(2): 226-233, 2022 11.
Article
in English
| MEDLINE | ID: mdl-36055813
3.
Screening, evaluation, and management of cancer-related fatigue: Ready for implementation to practice?
CA Cancer J Clin
; 65(3): 190-211, 2015.
Article
in English
| MEDLINE | ID: mdl-25760293
4.
The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners.
Support Care Cancer
; 30(2): 1427-1439, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34524527
5.
Exercise counselling and referral in cancer care: an international scoping survey of health care practitioners' knowledge, practices, barriers, and facilitators.
Support Care Cancer
; 30(11): 9379-9391, 2022 Nov.
Article
in English
| MEDLINE | ID: mdl-36173560
6.
Systematic Review of Functional Outcomes in Cancer Rehabilitation.
Arch Phys Med Rehabil
; 103(9): 1807-1826, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35104445
7.
Trajectories of fatigue in a population-based sample of older adult breast, prostate, and colorectal cancer survivors: an analysis using the SEER-MHOS data resource.
Support Care Cancer
; 29(12): 7393-7402, 2021 Dec.
Article
in English
| MEDLINE | ID: mdl-34052930
8.
Rehabilitation Interventions in the Multidisciplinary Management of Patients With Sclerotic Graft-Versus-Host Disease of the Skin and Fascia.
Arch Phys Med Rehabil
; 102(4): 776-788, 2021 04.
Article
in English
| MEDLINE | ID: mdl-33347890
9.
International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium.
Lancet Oncol
; 21(2): e83-e96, 2020 02.
Article
in English
| MEDLINE | ID: mdl-32007209
10.
Clinical characteristics and cytokine biomarkers in patients with chronic graft-vs-host disease persisting seven or more years after diagnosis.
Am J Hematol
; 95(4): 387-394, 2020 04.
Article
in English
| MEDLINE | ID: mdl-31903638
11.
Motor ability, function, and health-related quality of life as correlates of symptom burden in patients with sclerotic chronic graft-versus-host disease receiving imatinib mesylate.
Support Care Cancer
; 28(8): 3679-3689, 2020 Aug.
Article
in English
| MEDLINE | ID: mdl-31811481
12.
Red cell distribution width as a new prognostic biomarker in refractory chronic graft-versus-host disease.
Haematologica
; 109(1): 298-302, 2024 Jan 01.
Article
in English
| MEDLINE | ID: mdl-37584292
13.
Evidence-based sizing of non-inferiority trials using decision models.
BMC Med Res Methodol
; 19(1): 3, 2019 01 07.
Article
in English
| MEDLINE | ID: mdl-30612554
14.
Fatigue predicts impaired social adjustment in survivors of allogeneic hematopoietic cell transplantation (HCT).
Support Care Cancer
; 27(4): 1355-1363, 2019 Apr.
Article
in English
| MEDLINE | ID: mdl-30136024
15.
Routine surveillance for symptomatic toxicities with real-time clinician reporting in Danish breast cancer patients-Organization and design of the first national, cluster randomized trial using the Patient-Reported Outcomes version of Common Terminology Criteria for Adverse Events (PRO-CTCAE).
Breast J
; 25(2): 269-272, 2019 03.
Article
in English
| MEDLINE | ID: mdl-30761667
16.
Statistical analysis of patient-reported outcome data in randomised controlled trials of locally advanced and metastatic breast cancer: a systematic review.
Lancet Oncol
; 19(9): e459-e469, 2018 09.
Article
in English
| MEDLINE | ID: mdl-30191850
17.
Outcomes of multidisciplinary treatment planning in US cancer care settings.
Cancer
; 124(18): 3656-3667, 2018 09 15.
Article
in English
| MEDLINE | ID: mdl-30216477
18.
Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop.
Value Health
; 21(6): 742-747, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29909880
19.
Moving forward toward standardizing analysis of quality of life data in randomized cancer clinical trials.
Clin Trials
; 15(6): 624-630, 2018 12.
Article
in English
| MEDLINE | ID: mdl-30141714
20.
National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: The Research Methodology and Study Design Working Group Report.
Biol Blood Marrow Transplant
; 23(1): 10-23, 2017 01.
Article
in English
| MEDLINE | ID: mdl-27590102